2024 Q4 Form 10-Q Financial Statement
#000141057824001879 Filed on November 12, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | $357.0K | |
YoY Change | -12.07% | |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | $8.130M | |
YoY Change | 12.9% | |
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $8.130M | |
YoY Change | 12.9% | |
Operating Profit | -$14.80M | |
YoY Change | 7.06% | |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | -$4.573M | |
YoY Change | -3.83% | |
Pretax Income | ||
YoY Change | ||
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$19.37M | |
YoY Change | 4.27% | |
Net Earnings / Revenue | -5426.89% | |
Basic Earnings Per Share | -$0.02 | |
Diluted Earnings Per Share | -$0.02 | |
COMMON SHARES | ||
Basic Shares Outstanding | 1.297B | 1.248B |
Diluted Shares Outstanding | 1.259M |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $2.939M | |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $5.192M | |
YoY Change | -38.57% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $17.32M | |
YoY Change | 3.41% | |
Goodwill | $626.0K | |
YoY Change | 0.0% | |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $374.0K | |
YoY Change | 4.76% | |
Total Long-Term Assets | $24.13M | |
YoY Change | 4.73% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $5.192M | |
Total Long-Term Assets | $24.13M | |
Total Assets | $29.32M | |
YoY Change | -6.89% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $59.56M | |
YoY Change | 21.01% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $34.00M | |
YoY Change | 72.38% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $59.56M | |
Total Long-Term Liabilities | $34.00M | |
Total Liabilities | $93.56M | |
YoY Change | 35.7% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$1.415B | |
YoY Change | 5.55% | |
Common Stock | $1.335B | |
YoY Change | 4.93% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$80.12M | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $29.32M | |
YoY Change | -6.89% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$19.37M | |
YoY Change | 4.27% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q3 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember | |
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember | ||
CY2024Q3 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001072379 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NONE | ||
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember | ||
CY2024Q3 | nwbo |
Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
|
0 | |
CY2024Q3 | nwbo |
Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
|
0 | |
CY2024Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
|
0 | |
CY2024Q3 | nwbo |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | |
CY2024Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
|
0 | |
CY2024Q3 | nwbo |
Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
|
400000 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-35737 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
NORTHWEST BIOTHERAPEUTICS, INC | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
94-3306718 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4800 Montgomery Lane | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 800 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Bethesda | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MD | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20814 | ||
dei |
City Area Code
CityAreaCode
|
240 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
497-9024 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
NWBO | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
1297445623 | |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2939000 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2126000 | |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2253000 | |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1999000 | |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
5192000 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4125000 | |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17322000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17278000 | |
CY2024Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4515000 | |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4183000 | |
CY2024Q3 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
1292000 | |
CY2023Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
1292000 | |
CY2024Q3 | us-gaap |
Goodwill
Goodwill
|
626000 | |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
626000 | |
CY2024Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
374000 | |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
361000 | |
CY2024Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
24129000 | |
CY2023Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
23740000 | |
CY2024Q3 | us-gaap |
Assets
Assets
|
29321000 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
27865000 | |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
17913000 | |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
10244000 | |
CY2024Q3 | nwbo |
Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
|
3043000 | |
CY2023Q4 | nwbo |
Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
|
3544000 | |
CY2024Q3 | nwbo |
Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
|
1825000 | |
CY2023Q4 | nwbo |
Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
|
3765000 | |
CY2024Q3 | nwbo |
Convertible Notes At Fair Value Current
ConvertibleNotesAtFairValueCurrent
|
19380000 | |
CY2023Q4 | nwbo |
Convertible Notes At Fair Value Current
ConvertibleNotesAtFairValueCurrent
|
12771000 | |
CY2024Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
7577000 | |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
3944000 | |
CY2024Q3 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
9193000 | |
CY2023Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
9188000 | |
CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
944000 | |
CY2024Q3 | us-gaap |
Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
|
207000 | |
CY2023Q4 | us-gaap |
Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
|
7000 | |
CY2024Q3 | nwbo |
Share Liability
ShareLiability
|
170000 | |
CY2023Q4 | nwbo |
Share Liability
ShareLiability
|
483000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
256000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
314000 | |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
59564000 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
45204000 | |
CY2024Q3 | nwbo |
Convertible Notes At Fair Value Non Current
ConvertibleNotesAtFairValueNonCurrent
|
3774000 | |
CY2024Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
20695000 | |
CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
20312000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4828000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4454000 | |
CY2024Q3 | nwbo |
Contingent Payment Obligation Noncurrent
ContingentPaymentObligationNoncurrent
|
4700000 | |
CY2023Q4 | nwbo |
Contingent Payment Obligation Noncurrent
ContingentPaymentObligationNoncurrent
|
4950000 | |
CY2024Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
33997000 | |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
29716000 | |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
93561000 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
74920000 | |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1700000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1700000000 | |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1286300000 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1286300000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1175500000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1175500000 | |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
1286000 | |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1175000 | |
CY2024Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1333981000 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1291316000 | |
CY2024Q3 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
79000 | |
CY2023Q4 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
79000 | |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1415276000 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1359721000 | |
CY2024Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-29000 | |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
1536000 | |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-80117000 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-65773000 | |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
29321000 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
27865000 | |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
357000 | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
406000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1151000 | ||
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1487000 | ||
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
357000 | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
406000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1151000 | ||
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1487000 | ||
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8130000 | |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7201000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
24365000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20276000 | ||
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7028000 | |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7030000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
24795000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21577000 | ||
CY2024Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
15158000 | |
CY2023Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
14231000 | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
49160000 | ||
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
41853000 | ||
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14801000 | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13825000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-48009000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-40366000 | ||
CY2024Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-1590000 | |
CY2023Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-112000 | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
939000 | ||
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
3875000 | ||
CY2024Q3 | nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
70000 | |
CY2023Q3 | nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
487000 | |
nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
31000 | ||
nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
534000 | ||
CY2024Q3 | nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
3087000 | |
CY2023Q3 | nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
-4942000 | |
nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
4621000 | ||
nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
-4942000 | ||
CY2024Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6820000 | |
CY2023Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-1768000 | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-9905000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-3648000 | ||
CY2024Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
2080000 | |
CY2023Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
1670000 | |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
5279000 | ||
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
3999000 | ||
CY2024Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
2760000 | |
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-1692000 | |
us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
2047000 | ||
us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-76000 | ||
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4573000 | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-9697000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-7546000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8256000 | ||
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19374000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23522000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-55555000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-48622000 | ||
CY2024Q3 | nwbo |
Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
|
132000 | |
CY2023Q3 | nwbo |
Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
|
519000 | |
nwbo |
Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
|
1141000 | ||
nwbo |
Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
|
1433000 | ||
CY2024Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-19506000 | |
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-24041000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56696000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-50055000 | ||
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
2253000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-1397000 | |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
1565000 | ||
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-145000 | ||
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-21759000 | |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-22644000 | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-58261000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-49910000 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1258532 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1134359 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1220472 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1106111 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1258532 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1134359 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1220472 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1106111 | ||
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-76497000 | |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
4987000 | |
CY2024Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
7114000 | |
CY2024Q3 | nwbo |
Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
|
26000 | |
CY2024Q3 | nwbo |
Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
|
4868000 | |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
685000 | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19374000 | |
CY2024Q3 | nwbo |
Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
|
459000 | |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
132000 | |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2253000 | |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-80117000 | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-61034000 | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2974000 | |
CY2023Q3 | nwbo |
Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
|
32000 | |
CY2023Q3 | nwbo |
Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
|
7920000 | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
1565000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23522000 | |
CY2023Q3 | nwbo |
Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
|
1126000 | |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
519000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
1397000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-70061000 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-65773000 | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
13721000 | ||
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
10011000 | ||
nwbo |
Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
|
1517000 | ||
nwbo |
Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
|
12968000 | ||
us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
3002000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-55555000 | ||
nwbo |
Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
|
2698000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
1141000 | ||
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-1565000 | ||
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-80117000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-128103000 | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
6536000 | ||
nwbo |
Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
|
2801000 | ||
nwbo |
Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
|
76258000 | ||
nwbo |
Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
|
17484000 | ||
us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
2673000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-48622000 | ||
nwbo |
Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
|
2200000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
|
1433000 | ||
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
145000 | ||
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-70061000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-55555000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-48622000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1307000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1101000 | ||
nwbo |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
1618000 | ||
nwbo |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
2006000 | ||
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
939000 | ||
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
3875000 | ||
nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
31000 | ||
nwbo |
Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
|
534000 | ||
nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
4621000 | ||
nwbo |
Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
|
-4942000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-9905000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-3648000 | ||
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
236000 | ||
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
211000 | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
3002000 | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
2833000 | ||
nwbo |
Warrant Modifications Associated With Convertible Notes Under Fair Value Option
WarrantModificationsAssociatedWithConvertibleNotesUnderFairValueOption
|
327000 | ||
nwbo |
Warrant Modifications Associated With Convertible Notes Under Fair Value Option
WarrantModificationsAssociatedWithConvertibleNotesUnderFairValueOption
|
287000 | ||
us-gaap |
Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
10804000 | ||
us-gaap |
Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
10619000 | ||
nwbo |
Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
|
216000 | ||
nwbo |
Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
|
-802000 | ||
nwbo |
Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
|
9000 | ||
nwbo |
Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
|
13000 | ||
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
8535000 | ||
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
2657000 | ||
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
-501000 | ||
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
-2239000 | ||
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
106000 | ||
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
117000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-36836000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-36679000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
936000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3019000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-936000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3019000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10011000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1517000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1598000 | ||
nwbo |
Payments To Investors
PaymentsToInvestors
|
-200000 | ||
nwbo |
Payments To Investors
PaymentsToInvestors
|
-7000 | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
12000000 | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
10000000 | ||
nwbo |
Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
|
9915000 | ||
nwbo |
Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
|
12699000 | ||
nwbo |
Proceeds From Contingent Payment Obligation
ProceedsFromContingentPaymentObligation
|
50000 | ||
nwbo |
Proceeds From Contingent Payment Obligation
ProceedsFromContingentPaymentObligation
|
4550000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
251000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
210000 | ||
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
800000 | ||
nwbo |
Repayment Of Investor Advances
RepaymentOfInvestorAdvances
|
200000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
40843000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
38343000 | ||
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-2258000 | ||
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
487000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
813000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-868000 | ||
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2126000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6965000 | |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2939000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6097000 | |
nwbo |
Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
|
3000 | ||
nwbo |
Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
|
21000 | ||
nwbo |
Reclassification Of Warrant Liabilities To Stockholders Deficit Non Cash Investing And Financing Activities
ReclassificationOfWarrantLiabilitiesToStockholdersDeficitNonCashInvestingAndFinancingActivities
|
76258000 | ||
nwbo |
Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
|
12968000 | ||
nwbo |
Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
|
17484000 | ||
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2679000 | ||
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
13721000 | ||
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
6536000 | ||
nwbo |
Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
|
238000 | ||
nwbo |
Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
|
71000 | ||
nwbo |
Issuance Of Convertible Preferred Stock In Lieu Of Debt Redemption
IssuanceOfConvertiblePreferredStockInLieuOfDebtRedemption
|
1013000 | ||
nwbo |
Deemed Dividend Related To Warrant Modification Non Cash Investing And Financing Activities
DeemedDividendRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
|
1141000 | ||
nwbo |
Deemed Dividend Related To Warrant Modification Non Cash Investing And Financing Activities
DeemedDividendRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
|
1433000 | ||
nwbo |
Debt Discount Related To Warrant Modification Non Cash Investing And Financing Activities
DebtDiscountRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
|
8000 | ||
nwbo |
Reclassification Between Contingent Payment Obligation And Convertible Notes Payable At Fair Value
ReclassificationBetweenContingentPaymentObligationAndConvertibleNotesPayableAtFairValue
|
300000 | ||
nwbo |
Reclassification Of Investor Advances To Convertible Notes Payable
ReclassificationOfInvestorAdvancesToConvertibleNotesPayable
|
1163000 | ||
nwbo |
Reclassification Of Investor Advances To Stockholders Deficit
ReclassificationOfInvestorAdvancesToStockholdersDeficit
|
1203000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
364000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-55600000 | ||
us-gaap |
Payments For Operating Activities
PaymentsForOperatingActivities
|
36800000 | ||
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Revision of Prior Period Consolidated Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">As previously disclosed in the 2023 Annual Report, the Company revised its prior period financial statements to reflect an adjustment related to the fair value of convertible notes that was not material, individually or in the aggregate, to the Company’s previously issued consolidated financial statements. The appropriate revisions to the Company’s historical condensed consolidated financial statements and the notes thereto are reflected herein. See Note 14 to the “Consolidated Financial Statements” in the 2023 Annual Report for additional information.</span></p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">On an ongoing basis, the Company evaluates its estimates and judgments, including valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets, and whether impairment charges may apply. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the reported amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates.</span></p> | ||
CY2024Q3 | nwbo |
Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
|
0 | |
CY2023Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
23386000 | |
nwbo |
Fair Value Of Additional Share Liability
FairValueOfAdditionalShareLiability
|
543000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
|
8615000 | ||
nwbo |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Debt Redemption
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDebtRedemption
|
-825000 | ||
nwbo |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Additions From Debt Extinguishment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsFromDebtExtinguishment
|
7189000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
800000 | ||
us-gaap |
Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
|
-5591000 | ||
CY2024Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
32517000 | |
CY2024Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
689000 | |
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1622000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2980000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2833000 | ||
CY2024Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
2200000 | |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y6M | ||
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
317076000 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.35 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
114097000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
500000 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.53 | ||
nwbo |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
|
P3Y8M12D | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
650000 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.35 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
316926000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.35 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y3M18D | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
9558000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
282679000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0.33 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P5Y2M12D | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
8718000 | |
CY2024Q3 | nwbo |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Subject To Block Letter Agreements
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumberSubjectToBlockLetterAgreements
|
153000000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
283000000 | |
nwbo |
Share Based Compensation Arrangement By Share Based Payment Award Period Of Notice For Exercising Any Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfNoticeForExercisingAnyOption
|
P61D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
500000 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.53 | ||
CY2024Q3 | nwbo |
Share Based Compensation Arrangement By Share Based Payment Award Additional Payment Per Option To Be Made For Exercise Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalPaymentPerOptionToBeMadeForExerciseOfOption
|
0.30 | |
CY2024Q3 | nwbo |
Share Based Compensation Arrangement By Share Based Payment Award Additional Payment To Be Made For Exercise Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalPaymentToBeMadeForExerciseOfOption
|
150000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
0.53 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P2Y1M6D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.73 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.045 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17322000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17278000 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1300000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1100000 | ||
CY2024Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
51838000 | |
CY2024Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1566000 | |
CY2024Q3 | nwbo |
Fair Value Adjustment Convertible Notes At Fair Value
FairValueAdjustmentConvertibleNotesAtFairValue
|
2979000 | |
CY2024Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
53251000 | |
CY2023Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
40769000 | |
CY2023Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1998000 | |
CY2023Q4 | nwbo |
Fair Value Adjustment Convertible Notes At Fair Value
FairValueAdjustmentConvertibleNotesAtFairValue
|
2021000 | |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
40792000 | |
us-gaap |
Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
|
800000 | ||
nwbo |
Accrued Share Liabilities
AccruedShareLiabilities
|
500000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
|
-3000000.0 | ||
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2700000 | ||
CY2024Q3 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
200000 | |
CY2024Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
2100000 | |
CY2023Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
1700000 | |
CY2024Q3 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
600000 | |
CY2023Q3 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
700000 | |
us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
5300000 | ||
us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
4000000.0 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1600000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2000000.0 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
505877000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
500497000 | ||
nwbo |
Percentage Of Margin
PercentageOfMargin
|
0.15 | ||
nwbo |
Ancillary Services Agreement Additional Term Of Agreement
AncillaryServicesAgreementAdditionalTermOfAgreement
|
P12M | ||
CY2024Q3 | us-gaap |
Area Of Land
AreaOfLand
|
88000 | |
CY2024Q3 | us-gaap |
Sublease Income
SubleaseIncome
|
36000 | |
CY2023Q3 | us-gaap |
Sublease Income
SubleaseIncome
|
36000 | |
us-gaap |
Sublease Income
SubleaseIncome
|
109000 | ||
us-gaap |
Sublease Income
SubleaseIncome
|
108000 | ||
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2700000 | ||
CY2024Q3 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
200000 | |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
200000 | |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.40 | |
nwbo |
Proceeds From Outstanding Warrant Exercises Including Investor Advances
ProceedsFromOutstandingWarrantExercisesIncludingInvestorAdvances
|
1500000 | ||
nwbo |
Stock Issued During Period Shares Warrant Exercises
StockIssuedDuringPeriodSharesWarrantExercises
|
6400000 | ||
nwbo |
Number Of Options Cash Less Exercise
NumberOfOptionsCashLessExercise
|
700000 | ||
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
105241000 | |
CY2023Q4 | nwbo |
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
|
0.31 | |
CY2023 | nwbo |
Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
|
P1Y9M29D | |
nwbo |
Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
|
244000 | ||
CY2024Q3 | nwbo |
Class Of Warrant Or Rights Granted Weighted Average Exercise Price
ClassOfWarrantOrRightsGrantedWeightedAverageExercisePrice
|
0.40 | |
nwbo |
Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
|
6421000 | ||
nwbo |
Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
|
0.24 | ||
nwbo |
Number Of Warrants Warrants Cashless Exercise
NumberOfWarrantsWarrantsCashlessExercise
|
4794000 | ||
nwbo |
Weighted Average Exercise Price Warrants Cashless Exercise
WeightedAverageExercisePriceWarrantsCashlessExercise
|
0.27 | ||
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
94270000 | |
CY2024Q3 | nwbo |
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
|
0.28 | |
nwbo |
Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
|
P2Y29D | ||
nwbo |
Class Of Warrant Or Right Extended In Suspension
ClassOfWarrantOrRightExtendedInSuspension
|
90000000 | ||
nwbo |
Share Based Payment Arrangement Plan Modification Associated With Debt Financing As Additional Debt Discount
ShareBasedPaymentArrangementPlanModificationAssociatedWithDebtFinancingAsAdditionalDebtDiscount
|
1600000 | ||
nwbo |
Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
|
1100000 | ||
CY2024Q3 | us-gaap |
Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
|
true | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P2Y | |
CY2024Q3 | nwbo |
Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
|
400000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5100000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P20Y | |
CY2024Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4500000 | |
CY2024Q3 | us-gaap |
Area Of Land
AreaOfLand
|
88000 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
661000 | ||
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
39000 | ||
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
24000 | ||
us-gaap |
Sublease Income
SubleaseIncome
|
109000 | ||
us-gaap |
Lease Cost
LeaseCost
|
615000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
364000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
704000 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
633000 | ||
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
62000 | ||
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
10000 | ||
us-gaap |
Sublease Income
SubleaseIncome
|
108000 | ||
us-gaap |
Lease Cost
LeaseCost
|
597000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
691000 | ||
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
174000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
929000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
886000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
696000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
696000 | |
CY2024Q3 | nwbo |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
6940000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
10321000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
5237000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5084000 | |
CY2022Q3 | nwbo |
Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
|
135000 | |
CY2022Q3 | nwbo |
Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
|
145000 | |
CY2023Q4 | us-gaap |
Loss Contingency Accrual Payments
LossContingencyAccrualPayments
|
189000 | |
CY2023Q4 | us-gaap |
Loss Contingency Accrual Payments
LossContingencyAccrualPayments
|
201000 | |
CY2024Q1 | us-gaap |
Loss Contingency Accrual Payments
LossContingencyAccrualPayments
|
189000 | |
CY2024Q1 | us-gaap |
Loss Contingency Accrual Payments
LossContingencyAccrualPayments
|
207000 | |
CY2024Q3 | nwbo |
Accrued Income Tax Liability Trade Tax
AccruedIncomeTaxLiabilityTradeTax
|
155000 | |
CY2024Q3 | nwbo |
Accrued Income Tax Liability Trade Tax
AccruedIncomeTaxLiabilityTradeTax
|
173000 | |
CY2024Q3 | nwbo |
Accrued Income Tax Liability Corporation Tax
AccruedIncomeTaxLiabilityCorporationTax
|
99000 | |
CY2024Q3 | nwbo |
Accrued Income Tax Liability Corporation Tax
AccruedIncomeTaxLiabilityCorporationTax
|
110000 | |
CY2024Q3 | us-gaap |
Former Gain Contingency Recognized In Current Period
FormerGainContingencyRecognizedInCurrentPeriod
|
50000000 | |
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |